We are seeking a Neonatologist to represent BAPM at a working group with BMFMS and BHS to advise on the development of a care pathway and specialist network for those at risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). The group will discuss:

  1. A joint BAPM, BMFMS and BHS care pathway for those at risk of FNAIT both pre-pregnancy, during pregnancy and after birth and then for those neonates and families when an FNAIT diagnosis is made in the neonatal period.
  2. Development of a specialist network for care of at risk pregnancies - this would also provide a route through which nipocalimab could be accessed under an early access to medicines scheme if shown to be safe and effective in Freesia 3 trial.

The first meeting is planned for 4 December. If you would be interested in this please can you email the BAPM office and include 1-2 paragraphs covering your interest and any relevant experience or expertise in this topic.